We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

50 hedge funds and large institutions have $184M invested in Agile Therapeutics in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 11

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

22% more capital invested

Capital invested by funds: $151M → $184M (+$33.2M)

4% more funds holding

Funds holding: 48 → 50 (+2)

Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.33%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
8
Increased
17
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$2.31M
2
CC
Caxton Corporation
New Jersey
+$1.04M
3
RA
Royce & Associates
New York
+$561K
4
BCM
Bridgeway Capital Management
Texas
+$301K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$288K

Top Sellers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
-$2.74M
2
RCM
RA Capital Management
Massachusetts
-$1.44M
3
SCM
Sio Capital Management
New York
-$1.03M
4
EI
EAM Investors
California
-$822K
5
JGC
J. Goldman & Co
New York
-$370K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWMAG
26
Pinnacle Wealth Management Advisory Group
New Jersey
$572K -$13.7K -1 -3%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$484K +$41.1K +3 +10%
FLAM
28
First Light Asset Management
Minnesota
$454K -$13.7K -1 -3%
BIM
29
BlackRock Investment Management
Delaware
$346K +$27.4K +2 +10%
T. Rowe Price Associates
30
T. Rowe Price Associates
Maryland
$313K +$288K +21 New
TCIM
31
TIAA CREF Investment Management
New York
$301K +$54.8K +4 +25%
COPPSERS
32
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$234K +$205K +15 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$212K -$13.7K -1 -7%
AP
34
AlpInvest Partners
Netherlands
$211K +$192K +14 New
RHJA
35
Rice Hall James & Associates
California
$193K – – –
TC
36
TFS Capital
Pennsylvania
$164K +$151K +11 New
TA
37
Teachers Advisors
New York
$148K +$41.1K +3 +43%
Charles Schwab
38
Charles Schwab
California
$103K – – –
JRP
39
Jasper Ridge Partners
California
$93K +$82.2K +6 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$72K – – –
GT
41
Glenmede Trust
Pennsylvania
$70K +$68.5K +5 New
NFA
42
Nationwide Fund Advisors
Ohio
$61K +$13.7K +1 +33%
AIG
43
American International Group
New York
$58.2K +$13.7K +1 +33%
JP Morgan Chase
44
JP Morgan Chase
New York
$46K +$41.1K +3 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$37K – – –
Wells Fargo
46
Wells Fargo
California
$34K -$13.7K -1 -33%
BA
47
BlackRock Advisors
Delaware
$34K – – –
Barclays
48
Barclays
United Kingdom
$26K +$27.4K +2 New
Morgan Stanley
49
Morgan Stanley
New York
$24K – – –
Deutsche Bank
50
Deutsche Bank
Germany
$15K – – –
1
2
3

AGRX Hedge Fund Activity: Q2 2016 in Review

50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q2 2016, worth a combined $184M — up 22% from $151M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AGRX positions and 6 closed out — a net gain of 2 holders — while 17 added to existing stakes and 11 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $2.31M. The largest seller was Aisling Capital, cutting an estimated $2.74M.

  • 50 institutional investors held Agile Therapeutics (AGRX) as of Q2 2016, up from 48 in Q1 2016.
  • Funds reported $184M of Agile Therapeutics stock for Q2 2016, up 22% quarter-over-quarter.
  • 8 funds opened new Agile Therapeutics positions in Q2 2016 and 6 closed out, a net change of +2 holders.
  • The largest Agile Therapeutics buyer in Q2 2016 was Perceptive Advisors, an estimated $2.31M added.
  • The largest Agile Therapeutics seller in Q2 2016 was Aisling Capital, an estimated $2.74M sold.

Based on aggregated 13F filings for Q2 2016.